While this test doesn't predict constipation risk directly, understanding your individual peptide-pathway genetics helps your provider tailor your semaglutide dosing and compound selection for optimal tolerability
Sources Amini, S., Burkholder, D
(similar for Retatrutide) Rosenstock J, et al
These outcomes raise important questions about the future direction of metabolic therapeutics and whether dual incretin agonism represents a superior and more physiologically aligned strategy for long term disease management
It is an investigational compound with individual variability in response, and its use should be part of a broader conversation with a knowledgeable healthcare provider about sleep health, hormonal balance, and overall longevity goals
This two-receptor strategy has been studied in the context of adult GH deficiency and age-related somatotropic decline, with investigators reporting that the combination produces supraadditive GH release compared with either compound administered alone
